Introduction of CEO
CEO
1987
M.D. Seoul National University College of medicine
1995
M.D./Ph.D. Graduate School of Medicine, Seoul National University
1998
Assistant Professor, SNUCM
1999 - 2000
University of Chicago, USA (Prof. Jeff Bluestone)
2001
Diabetes Center, UCSF, USA (Prof. Jeff Bluestone)
2004
Associate Professor, SNUCM
2009 - present
Professor, SNUCM
2010 - 2012
Vice President of Research, SNUCM
2012 - 2016
Head professor, Department of microbiology and immunology, SNUCM
2012 - 2016
Director, International Xenotransplantation Association (IXA)
2017
President of the Korean Immunology Association
2016 - present
Associate editor, Xenotransplantation(Journal)
2017 - present
Asian Pancreatic/Pancreatic Islet Transplantation Association (Chairman of External Cooperation)
2020 - present
Editorial board member, Cytokine(Journal)
2021 - present
PB Immune Therapeutics Co
Management Team
Kun-Sang Park
CIO
"Bio value chain operation experience"
1990
SNUCM M.D
1994
SNU Hospital Internal Medicine Specialist & Full-time Physician
2001
Clinical Lecturer, Dept. of Endocrinology, Samsung Seoul Hospital
2020
SNU Genomics Research Center
2021-present
PB Immune Therapeutics Co.
Jung-Sik Kim
COO
"Design and administration of business operations and technology"
2002–2005
PhD, Seoul National University College of Medicine, Immunology
2006–2013
Research professor, Seoul National University Hospital
2013-2019
Research Professor, Seoul National University, College of Medicine
2019-2021
DiNonA. InC (Kumho HT) CTO, Executive director
2021-present
PB Immune Therapeutics Co.
Hyun-Je Kim
CTO
"Introduce the latest immunology research techniques"
2007
Bachelor of Medicine, SNUCM (Medicine)
2012
Specialist, Samsung Seoul Hospital (Dermatology)
2017
Doctor of Medicine, SNU Graduate School of Medicine (Immunology)
2017-2019
Instructor, Ichan School of Medicine at Mount Sinai
2020
Samsung Seoul Hospital Dermatology Research Lecturer
2021-present
Institute of Infectious Diseases, SNUCM
2021-present
PB Immune Therapeutics Co.
Jong-Min Kim
CDO
"Rich preclinical experience in primates"
2004
Bachelor of Veterinary Medicine, Chungbuk National University
2011
Doctor of Veterinary Medicine, Chungbuk National University
2006-2009
SNU Hospital Preclinical Experiment Department, Senior Animal Team Leader
2013-present
Research Assistant Professor, SNU
2021-present
PB Immune Therapeutics Co.
Chang-Ho Lee
CRDO
"Extensive experience in research and development of gene therapy"
2005
B.S., Molecular Biology, Dankook university
2007
M.S., Molecular Biology, Dankook university
2012
PhD., Molecular Biology, Dankook university
2012-2021
Research Professor, Dept. of Molecular biology, Dankook University
2021-2022
General manager of CMC Team, ANL BIO CO.
2022-present
PB Immune Therapeutics Co.